Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 206

1.

Where is lupus hidden?

Hiepe F.

Presse Med. 2014 Jun;43(6 Pt 2):e143-50. doi: 10.1016/j.lpm.2014.04.005. Epub 2014 Jun 4. Review.

PMID:
24908395
[PubMed - indexed for MEDLINE]
2.

The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity.

Medgyesi D, Hobeika E, Biesen R, Kollert F, Taddeo A, Voll RE, Hiepe F, Reth M.

J Exp Med. 2014 Mar 10;211(3):427-40. doi: 10.1084/jem.20131196. Epub 2014 Mar 3.

PMID:
24590766
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?

Kyogoku C, Smiljanovic B, Grün JR, Biesen R, Schulte-Wrede U, Häupl T, Hiepe F, Alexander T, Radbruch A, Grützkau A.

PLoS One. 2013 Dec 31;8(12):e83776. doi: 10.1371/journal.pone.0083776. eCollection 2013.

PMID:
24391825
[PubMed - in process]
Free PMC Article
4.

Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.

Cheng Q, Mumtaz IM, Khodadadi L, Radbruch A, Hoyer BF, Hiepe F.

Ann Rheum Dis. 2013 Dec;72(12):2011-7. doi: 10.1136/annrheumdis-2013-203455. Epub 2013 Oct 10.

PMID:
24114925
[PubMed - indexed for MEDLINE]
5.

Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients.

Kohler S, Keil TO, Swierzy M, Hoffmann S, Schaffert H, Ismail M, Rückert JC, Alexander T, Hiepe F, Gross C, Thiel A, Meisel A.

J Neuroimmunol. 2013 Nov 15;264(1-2):114-9. doi: 10.1016/j.jneuroim.2013.09.006. Epub 2013 Sep 18.

PMID:
24099983
[PubMed - indexed for MEDLINE]
6.

[Statement on the use of mycophenolate mofetil for systemic lupus erythematosus].

Aringer M, Fischer-Betz R, Hiepe F; Kommission Pharmakotherapie der DGRh; Germany Society of Rheumatology.

Z Rheumatol. 2013 Aug;72(6):575-80. doi: 10.1007/s00393-013-1213-y. German.

PMID:
23756593
[PubMed - indexed for MEDLINE]
7.

Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response.

Enghard P, Rieder C, Kopetschke K, Klocke JR, Undeutsch R, Biesen R, Dragun D, Gollasch M, Schneider U, Aupperle K, Humrich JY, Hiepe F, Backhaus M, Radbruch AH, Burmester GR, Riemekasten G.

Ann Rheum Dis. 2014 Jan;73(1):277-83. doi: 10.1136/annrheumdis-2012-202784. Epub 2013 Mar 8.

PMID:
23475982
[PubMed - indexed for MEDLINE]
8.

Development and resolution of secondary autoimmunity after autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: competition of plasma cells for survival niches?

Alexander T, Schneider S, Hoyer B, Cheng Q, Thiel A, Ziemer S, Burmester GR, Arnold R, Radbruch A, Hiepe F.

Ann Rheum Dis. 2013 Jun;72(6):1102-4. doi: 10.1136/annrheumdis-2012-202729. Epub 2013 Jan 29. No abstract available.

PMID:
23361083
[PubMed - indexed for MEDLINE]
9.

Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.

Alexander T, Sattler A, Templin L, Kohler S, Groß C, Meisel A, Sawitzki B, Burmester GR, Arnold R, Radbruch A, Thiel A, Hiepe F.

Ann Rheum Dis. 2013 Sep 1;72(9):1549-58. doi: 10.1136/annrheumdis-2012-202216. Epub 2012 Dec 21.

PMID:
23264341
[PubMed - indexed for MEDLINE]
10.

Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy.

Winter O, Dame C, Jundt F, Hiepe F.

J Immunol. 2012 Dec 1;189(11):5105-11. doi: 10.4049/jimmunol.1202317. Review.

PMID:
23169863
[PubMed - indexed for MEDLINE]
Free Article
11.

Lupus nephritis: Transatlantic management recommendations compared.

Hiepe F.

Nat Rev Rheumatol. 2012 Dec;8(12):697-8. doi: 10.1038/nrrheum.2012.192. Epub 2012 Nov 13. No abstract available.

PMID:
23147901
[PubMed - indexed for MEDLINE]
12.

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.

Rose T, Grützkau A, Hirseland H, Huscher D, Dähnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P, Radbruch A, Riemekasten G, Burmester GR, Hiepe F, Biesen R.

Ann Rheum Dis. 2013 Oct;72(10):1639-45. doi: 10.1136/annrheumdis-2012-201586. Epub 2012 Oct 31.

PMID:
23117242
[PubMed - indexed for MEDLINE]
13.

Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).

Roll P, Ostermeier E, Haubitz M, Lovric S, Unger L, Holle J, Kötter I, Henes JC, Bergner R, Rubbert-Roth A, Specker C, Schulze-Koops H, Müller-Ladner U, Fleck M, Burmester GR, Hiepe F, Heitmann S, Aringer M, Fischer-Betz R, Dörner T, Tony HP.

J Rheumatol. 2012 Nov;39(11):2153-6. doi: 10.3899/jrheum.120482. Epub 2012 Sep 15.

PMID:
22984269
[PubMed - indexed for MEDLINE]
14.

[Neurological manifestations in connective tissue disease].

Harms L, Hiepe F.

Z Rheumatol. 2012 Sep;71(7):564-71. doi: 10.1007/s00393-012-0958-z. German.

PMID:
22930107
[PubMed - indexed for MEDLINE]
15.

Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.

Mumtaz IM, Hoyer BF, Panne D, Moser K, Winter O, Cheng QY, Yoshida T, Burmester GR, Radbruch A, Manz RA, Hiepe F.

J Autoimmun. 2012 Sep;39(3):180-8. doi: 10.1016/j.jaut.2012.05.010. Epub 2012 Jun 20.

PMID:
22727274
[PubMed - indexed for MEDLINE]
16.

The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.

Smiljanovic B, Grün JR, Biesen R, Schulte-Wrede U, Baumgrass R, Stuhlmüller B, Maslinski W, Hiepe F, Burmester GR, Radbruch A, Häupl T, Grützkau A.

J Mol Med (Berl). 2012 Nov;90(11):1295-309. doi: 10.1007/s00109-012-0907-y. Epub 2012 May 19.

PMID:
22610275
[PubMed - indexed for MEDLINE]
17.

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.

Stohl W, Hiepe F, Latinis KM, Thomas M, Scheinberg MA, Clarke A, Aranow C, Wellborne FR, Abud-Mendoza C, Hough DR, Pineda L, Migone TS, Zhong ZJ, Freimuth WW, Chatham WW; BLISS-52 Study Group; BLISS-76 Study Group.

Arthritis Rheum. 2012 Jul;64(7):2328-37. doi: 10.1002/art.34400.

PMID:
22275291
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.

Aringer M, Burkhardt H, Burmester GR, Fischer-Betz R, Fleck M, Graninger W, Hiepe F, Jacobi AM, Kötter I, Lakomek HJ, Lorenz HM, Manger B, Schett G, Schmidt RE, Schneider M, Schulze-Koops H, Smolen JS, Specker C, Stoll T, Strangfeld A, Tony HP, Villiger PM, Voll R, Witte T, Dörner T.

Lupus. 2012 Apr;21(4):386-401. doi: 10.1177/0961203311426569. Epub 2011 Nov 9. Review.

PMID:
22072024
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis.

Zeher M, Doria A, Lan J, Aroca G, Jayne D, Boletis I, Hiepe F, Prestele H, Bernhardt P, Amoura Z.

Lupus. 2011 Dec;20(14):1484-93. doi: 10.1177/0961203311418269. Epub 2011 Oct 5.

PMID:
21976398
[PubMed - indexed for MEDLINE]
20.

Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab.

Hoyer BF, Mumtaz IM, Loddenkemper K, Bruns A, Sengler C, Hermann KG, Maza S, Keitzer R, Burmester GR, Buttgereit F, Radbruch A, Hiepe F.

Ann Rheum Dis. 2012 Jan;71(1):75-9. doi: 10.1136/ard.2011.153007. Epub 2011 Sep 27.

PMID:
21953334
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk